Please provide your email address to receive an email when new articles are posted on . WAIKOLOA, Hawaii — It is important for physicians to consider “the perils that dwell” in the diagnostic ...

Some targeted biologics seemed very promising but subsequently failed in phase-3 clinical trials, noted Dr. Rosenbaum. In some cases, higher intravenous doses might yet prove effective. One concern ...

Patients being treated with immune checkpoint inhibitors may be at higher risk for developing uveitis, according to a speaker ...

Slower tapering of adalimumab reduced the recurrence risk for noninfectious uveitis by 60% in pediatric patients compared with faster tapering, and starting the tapering after at least 2 years of ...

New treatment guidance has been developed to help doctors tackle uveitis—one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help ...

Studies have highlighted a need for a standardized approach to screening for cytomegalovirus (CMV) retinitis in transplant patients, as there are no national ophthalmic screening guidelines for this ...

To assess the effectiveness of anti-tuberculous treatment in patients with chronic uveitis and either active systemic or latent tuberculosis (TB) in a non-endemic community. Retrospective study of ...

Until recently, fluorescein FA was the primary imaging modality used to detect macular edema and other features related with uveitis like choroidal neovascularization and serous retinal detachment.

Never heard of uveitis? It’s time to learn about the eye condition that, without treatment, can cause permanent damage. If you have psoriatic arthritis, you’re probably familiar with the symptoms that ...

For patients with chronic or recurrent uveitis, whose uveitis is not controlled within 3 months of treatment with ≤10mg/day, steroid-sparing therapies have become the standard of care. 4 “In some ...